Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Reynolds

Showing results (381-390 of 560) with videos related to

Pageof 56
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 19, 2018
Patient experiences of a physiotherapy-led multidisciplinary rehabilitative intervention after successful treatment for oesophago-gastric cancerA E Bennett, L O'Neill, D Connolly, et al.
Archives of Osteoporosis|January 11, 2019
Risk factors for loss of bone mineral density after curative esophagectomyJessie A Elliott, Sean Casey, Conor F Murphy, et al.
The American Journal of Gastroenterology|March 30, 2004
Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomyJ M O'Riordan, O N Tucker, P J Byrne, et al.
HRB Open Research|January 5, 2021
Patient and family co-developed participant information to improve recruitment rates, retention, and patient understanding in the Rehabilitation Strategies Following Oesophago-gastric and Hepatopancreaticobiliary Cancer (ReStOre II) trial: Protocol for a study within a trial (SWAT)Linda O'Neill, Peter Knapp, Suzanne L Doyle, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2020
CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapiesAshanty M Melo, Melissa J Conroy, Emma K Foley, et al.
International Journal of Molecular Sciences|September 13, 2019
Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett's Esophagus Compared to Esophageal AdenocarcinomaNaoimh J O'Farrell, James J Phelan, Ronan Feighery, et al.
International Journal of Colorectal Disease|September 19, 2019
Prophylactic negative wound therapy in laparotomy wounds (PROPEL trial): randomized controlled trialNoel Edward Donlon, P A Boland, M E Kelly, et al.
British Journal of Cancer|December 3, 2009
Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgeryM Byrne, J V Reynolds, J S O'Donnell, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 2, 2010
Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancerL A Healy, A M Ryan, P Carroll, et al.
The American Journal of Gastroenterology|December 8, 2011
IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesitySuzanne L Doyle, Claire L Donohoe, Stephen P Finn, et al.
Pageof 56

Showing results (381-390 of 560) with videos related to

Sort By:
Pageof 56
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 19, 2018
Patient experiences of a physiotherapy-led multidisciplinary rehabilitative intervention after successful treatment for oesophago-gastric cancerA E Bennett, L O'Neill, D Connolly, et al.
Archives of Osteoporosis|January 11, 2019
Risk factors for loss of bone mineral density after curative esophagectomyJessie A Elliott, Sean Casey, Conor F Murphy, et al.
The American Journal of Gastroenterology|March 30, 2004
Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomyJ M O'Riordan, O N Tucker, P J Byrne, et al.
HRB Open Research|January 5, 2021
Patient and family co-developed participant information to improve recruitment rates, retention, and patient understanding in the Rehabilitation Strategies Following Oesophago-gastric and Hepatopancreaticobiliary Cancer (ReStOre II) trial: Protocol for a study within a trial (SWAT)Linda O'Neill, Peter Knapp, Suzanne L Doyle, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2020
CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapiesAshanty M Melo, Melissa J Conroy, Emma K Foley, et al.
International Journal of Molecular Sciences|September 13, 2019
Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett's Esophagus Compared to Esophageal AdenocarcinomaNaoimh J O'Farrell, James J Phelan, Ronan Feighery, et al.
International Journal of Colorectal Disease|September 19, 2019
Prophylactic negative wound therapy in laparotomy wounds (PROPEL trial): randomized controlled trialNoel Edward Donlon, P A Boland, M E Kelly, et al.
British Journal of Cancer|December 3, 2009
Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgeryM Byrne, J V Reynolds, J S O'Donnell, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 2, 2010
Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancerL A Healy, A M Ryan, P Carroll, et al.
The American Journal of Gastroenterology|December 8, 2011
IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesitySuzanne L Doyle, Claire L Donohoe, Stephen P Finn, et al.
Pageof 56